Indeed, recent trial results demonstrate the exciting application of BTKis to prevent IgE-mediated anaphylaxis to foods, although additional clinical trials are needed to determine optimal dosing, duration of protection, and factors predictive of efficacy. This evidence concerns the gene IGHE and anaphylaxis.